Detalhe da pesquisa
1.
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.
Blood
; 118(3): 703-11, 2011 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21613259
2.
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.
Blood
; 116(20): 4231-9, 2010 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20702781
3.
Recent advances in novel radioimmunotherapeutic approaches for allogeneic hematopoietic cell transplantation.
Curr Opin Oncol
; 22(2): 143-9, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20019612
4.
Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
Bioconjug Chem
; 21(7): 1225-38, 2010 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-20597486
5.
Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE.
BMC Med Genet
; 9: 62, 2008 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18606005
6.
Nonresponse to neoadjuvant chemotherapy for muscle-invasive urothelial cell carcinoma of the bladder.
Clin Genitourin Cancer
; 12(3): 210-3, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24361053
7.
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer.
Adv Urol
; 2013: 317190, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24382958
8.
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.
Clin Cancer Res
; 17(23): 7373-82, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21976541
9.
Cost-benefit analysis of a method using diatomaceous earth to purify Tamm-Horsfall protein.
Biotechniques
; 36(1): 64-6, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14740486